Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Radiation-Induced Oral Mucositis
NCT00698204Phase 2Completed
- Sponsor
- UConn Health
- Start
- Jul 2003
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of celecoxib in oral mucositis (OM) (2 arms), sponsored by UConn Health. Primary endpoint: Clinical Oral Mucosal Injury Score at Cumulative Radiation Dose of 5000 cGy at 5 weeks. Started Jul 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00698204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698204.